Skip to content

Clinical trials

Observational Kidney Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Observational Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20032
20041
20051
20065
20075
20081
20093
20102
20111
20125
20135
20145
20151
20161
20175
20184
20195
20205
20218
20224
20233
20241
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting16
Active, not recruiting5
Terminated5
Unknown status5
Enrolling by invitation4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)10
National Institute of Allergy and Infectious Diseases (NIAID)4
George Washington University3
University of Michigan3
Baxter Healthcare Corporation2
Boston Children's Hospital2
Brigham and Women's Hospital2
Mayo Clinic2
National Center for Research Resources (NCRR)2
Renal Research Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases94
Kidney Failure, Chronic17
Renal Insufficiency17
Renal Insufficiency, Chronic17
Proteinuria8
Acute Kidney Injury7
Diabetes Mellitus7
Diabetic Nephropathies6
Cardiovascular Diseases5
Hypertension5

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.